Today, the Governments of Canada and Alberta signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest a total amount of over ...
Hepatitis B virus is a viral infection which affects the liver and can result in permanent liver damage. It is currently the leading cause of chronic liver | Immunology ...
We appreciate FDA’s support in designating REVASCOR both RMAT and RPD status, a recognition of the potential impact of our therapy on the long-term adverse outcomes of these desperately ill children.